TRAW
Traws Pharma Inc
NASDAQ · Pharmaceuticals
$1.96
+0.24 (+13.95%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.81M | 4.77M | 3.83M |
| Net Income | 633.7K | 796.1K | 510.0K |
| EPS | — | — | — |
| Profit Margin | 13.2% | 16.7% | 13.3% |
| Rev Growth | +22.7% | +21.0% | +9.5% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 6.83M | 5.75M | 5.44M |
| Total Equity | 8.41M | 8.92M | 7.51M |
| D/E Ratio | 0.81 | 0.64 | 0.73 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 1.15M | 1.15M | 1.01M |
| Free Cash Flow | 870.8K | 772.5K | 534.0K |